DK2501703T3 - Spiropiperidinforbindelser som orl-1-receptorantagonister - Google Patents
Spiropiperidinforbindelser som orl-1-receptorantagonisterInfo
- Publication number
- DK2501703T3 DK2501703T3 DK10782482.3T DK10782482T DK2501703T3 DK 2501703 T3 DK2501703 T3 DK 2501703T3 DK 10782482 T DK10782482 T DK 10782482T DK 2501703 T3 DK2501703 T3 DK 2501703T3
- Authority
- DK
- Denmark
- Prior art keywords
- spiropiperide
- orl
- compounds
- receptor antagonists
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09382246 | 2009-11-16 | ||
US29862910P | 2010-01-27 | 2010-01-27 | |
PCT/US2010/056180 WO2011060035A1 (en) | 2009-11-16 | 2010-11-10 | Spiropiperidine compounds as orl-1 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2501703T3 true DK2501703T3 (da) | 2013-10-14 |
Family
ID=41728051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10782482.3T DK2501703T3 (da) | 2009-11-16 | 2010-11-10 | Spiropiperidinforbindelser som orl-1-receptorantagonister |
Country Status (34)
Country | Link |
---|---|
US (1) | US8232289B2 (da) |
EP (1) | EP2501703B1 (da) |
JP (1) | JP5680101B2 (da) |
KR (1) | KR101363830B1 (da) |
CN (1) | CN102612520B (da) |
AR (1) | AR078863A1 (da) |
AU (1) | AU2010319581C1 (da) |
CA (1) | CA2796161C (da) |
CO (1) | CO6541545A2 (da) |
CR (1) | CR20130087A (da) |
DK (1) | DK2501703T3 (da) |
DO (1) | DOP2012000135A (da) |
EA (1) | EA020848B1 (da) |
EC (1) | ECSP12011902A (da) |
ES (1) | ES2435814T3 (da) |
HK (1) | HK1169988A1 (da) |
HN (1) | HN2012001011A (da) |
HR (1) | HRP20130967T1 (da) |
IL (1) | IL219370A (da) |
JO (1) | JO2887B1 (da) |
MA (1) | MA33751B1 (da) |
ME (1) | ME01537B (da) |
MX (1) | MX2012005691A (da) |
MY (1) | MY160665A (da) |
NZ (1) | NZ600006A (da) |
PE (1) | PE20121430A1 (da) |
PL (1) | PL2501703T3 (da) |
PT (1) | PT2501703E (da) |
RS (1) | RS53018B (da) |
SI (1) | SI2501703T1 (da) |
TW (1) | TWI465453B (da) |
UA (1) | UA107943C2 (da) |
WO (1) | WO2011060035A1 (da) |
ZA (1) | ZA201202967B (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8710245B2 (en) * | 2009-12-04 | 2014-04-29 | Psychogenics Inc. | Multicyclic compounds and methods of use thereof |
JP2013540145A (ja) * | 2010-10-21 | 2013-10-31 | ウニベルシテート デス ザールランデス | コルチゾール依存性疾患の治療用の選択的cyp11b1阻害剤 |
TWI582096B (zh) | 2011-12-06 | 2017-05-11 | 美國禮來大藥廠 | 用於酒精依賴及濫用處理之4',5'-二氫螺[哌啶-4,7'-噻吩并[2,3-c]哌喃]化合物 |
TW201416370A (zh) | 2012-07-31 | 2014-05-01 | Lilly Co Eli | 用於治療焦慮之orl-1受體拮抗劑 |
CN108477173B (zh) | 2012-10-02 | 2021-07-02 | 拜耳农作物科学股份公司 | 作为杀虫剂的杂环化合物 |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
TW201607923A (zh) | 2014-07-15 | 2016-03-01 | 歌林達有限公司 | 被取代之氮螺環(4.5)癸烷衍生物 |
AR105821A1 (es) * | 2015-09-09 | 2017-11-15 | Lilly Co Eli | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T |
EP3490607A4 (en) | 2016-07-29 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | COMPOUNDS AND COMPOSITIONS, AND USES THEREOF |
CN116514761A (zh) | 2016-07-29 | 2023-08-01 | 赛诺维信制药公司 | 化合物、组合物及其用途 |
CA3053903A1 (en) | 2017-02-16 | 2018-08-23 | Sunovion Pharmaceuticals Inc. | Methods of treating schizophrenia |
LT3589637T (lt) * | 2017-03-02 | 2021-06-25 | Eli Lilly And Company | Junginiai, naudotini ror-gama-t slopinimui |
LT3589638T (lt) | 2017-03-02 | 2021-06-10 | Eli Lilly And Company | Junginiai, naudingi ror-gama-t slopinimui |
SG11202000669VA (en) | 2017-08-02 | 2020-02-27 | Sunovion Pharmaceuticals Inc | Isochroman compounds and uses thereof |
MX2020008537A (es) | 2018-02-16 | 2021-01-08 | Sunovion Pharmaceuticals Inc | Sales, formas cristalinas y metodos de produccion de las mismas. |
KR20210139376A (ko) | 2019-03-14 | 2021-11-22 | 선오비온 파마슈티컬스 인코포레이티드 | 이소크로마닐 화합물의 염, 및 이의 결정성 형태, 제조방법, 치료 용도 및 약제학적 조성물 |
KR20230003503A (ko) | 2020-04-14 | 2023-01-06 | 선오비온 파마슈티컬스 인코포레이티드 | 신경학적 및 정신의학적 장애의 치료를 위한 (S)-(4,5-디히드로-7H-티에노[2,3-c]피란-7-일)-N-메틸메탄아민 |
WO2022047031A1 (en) | 2020-08-26 | 2022-03-03 | Vertex Pharmaceuticals Incorporated | Inhibitors of apol1 and methods of using same |
WO2023154344A1 (en) * | 2022-02-08 | 2023-08-17 | Vertex Pharmaceuticals Incorporated | 2-methyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL96507A0 (en) | 1989-12-08 | 1991-08-16 | Merck & Co Inc | Nitrogen-containing spirocycles and pharmaceutical compositions containing them |
DE60033071T2 (de) * | 1999-12-06 | 2007-08-23 | Euro-Celtique S.A. | Triazospiroverbindungen mit nociceptin-rezeptoraffinität |
HUP0401333A3 (en) * | 2001-04-18 | 2004-11-29 | Euro Celtique Sa | Spiropyrazole compounds and pharmaceutical compositions containing them |
WO2002088089A1 (fr) | 2001-04-19 | 2002-11-07 | Banyu Pharmaceutical Co., Ltd. | Derives de spiropiperidine, antagonistes du recepteur de nociceptine les contenant en tant qu'ingredient actif et compositions medicinales |
DE60226874D1 (de) * | 2001-07-23 | 2008-07-10 | Banyu Pharma Co Ltd | 4-oxoimidazolidin-2-spiro piperidin derivat |
EP1470126A1 (en) * | 2002-01-28 | 2004-10-27 | Pfizer Inc. | N-substituted spiropiperidine compounds as ligands for orl-1 receptor |
JPWO2003095427A1 (ja) | 2002-05-10 | 2005-09-15 | 大正製薬株式会社 | スピロ環化合物 |
US6995168B2 (en) * | 2002-05-31 | 2006-02-07 | Euro-Celtique S.A. | Triazaspiro compounds useful for treating or preventing pain |
NZ538307A (en) * | 2002-09-09 | 2008-04-30 | Janssen Pharmaceutica Nv | Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
WO2005016913A1 (en) * | 2003-08-19 | 2005-02-24 | Pfizer Japan, Inc. | Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders |
DE10360792A1 (de) * | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
BRPI0509307A (pt) * | 2004-03-29 | 2007-09-04 | Pfizer | compostos de alfa aril ou heteroaril metil beta piperidino propanamida como antagonistas do receptor orl1 |
DE102004039382A1 (de) * | 2004-08-13 | 2006-02-23 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
EP2020414A1 (en) | 2007-06-20 | 2009-02-04 | Laboratorios del Dr. Esteve S.A. | spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
DK2260042T3 (da) * | 2008-03-27 | 2011-10-31 | Gruenenthal Gmbh | Substituerede spirocykliske cyklohexan-derivater |
-
2010
- 2010-10-11 UA UAA201205367A patent/UA107943C2/uk unknown
- 2010-11-02 AR ARP100104035A patent/AR078863A1/es active IP Right Grant
- 2010-11-03 JO JO2010386A patent/JO2887B1/en active
- 2010-11-05 TW TW099138241A patent/TWI465453B/zh not_active IP Right Cessation
- 2010-11-10 PE PE2012000659A patent/PE20121430A1/es active IP Right Grant
- 2010-11-10 MX MX2012005691A patent/MX2012005691A/es active IP Right Grant
- 2010-11-10 PT PT107824823T patent/PT2501703E/pt unknown
- 2010-11-10 EA EA201290352A patent/EA020848B1/ru not_active IP Right Cessation
- 2010-11-10 WO PCT/US2010/056180 patent/WO2011060035A1/en active Application Filing
- 2010-11-10 ES ES10782482T patent/ES2435814T3/es active Active
- 2010-11-10 CA CA2796161A patent/CA2796161C/en not_active Expired - Fee Related
- 2010-11-10 AU AU2010319581A patent/AU2010319581C1/en not_active Ceased
- 2010-11-10 DK DK10782482.3T patent/DK2501703T3/da active
- 2010-11-10 PL PL10782482T patent/PL2501703T3/pl unknown
- 2010-11-10 CN CN201080051850.4A patent/CN102612520B/zh not_active Expired - Fee Related
- 2010-11-10 JP JP2012538935A patent/JP5680101B2/ja not_active Expired - Fee Related
- 2010-11-10 US US12/943,187 patent/US8232289B2/en active Active
- 2010-11-10 EP EP10782482.3A patent/EP2501703B1/en active Active
- 2010-11-10 ME MEP-2013-118A patent/ME01537B/me unknown
- 2010-11-10 MY MYPI2012002117A patent/MY160665A/en unknown
- 2010-11-10 KR KR1020127012498A patent/KR101363830B1/ko active IP Right Grant
- 2010-11-10 RS RS20130485A patent/RS53018B/en unknown
- 2010-11-10 NZ NZ600006A patent/NZ600006A/en not_active IP Right Cessation
- 2010-11-10 SI SI201030388T patent/SI2501703T1/sl unknown
-
2012
- 2012-04-23 IL IL219370A patent/IL219370A/en not_active IP Right Cessation
- 2012-04-23 ZA ZA2012/02967A patent/ZA201202967B/en unknown
- 2012-05-04 CO CO12073055A patent/CO6541545A2/es active IP Right Grant
- 2012-05-11 DO DO2012000135A patent/DOP2012000135A/es unknown
- 2012-05-11 HN HN2012001011A patent/HN2012001011A/es unknown
- 2012-05-14 MA MA34869A patent/MA33751B1/fr unknown
- 2012-05-16 EC ECSP12011902 patent/ECSP12011902A/es unknown
- 2012-10-26 HK HK12110735.5A patent/HK1169988A1/xx not_active IP Right Cessation
-
2013
- 2013-02-26 CR CR20130087A patent/CR20130087A/es unknown
- 2013-10-11 HR HRP20130967AT patent/HRP20130967T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2501703T3 (da) | Spiropiperidinforbindelser som orl-1-receptorantagonister | |
CY2020010I1 (el) | Ενωσεις oi οποιες τροποποιουν τον υποδοχεα ανδρογονου | |
FR22C1044I1 (fr) | Antagonistes du recepteur cgrp | |
DK2501704T3 (da) | Spiropiperidinforbindelser som oral-1-receptorantagonister | |
PL2927224T3 (pl) | Antagoniści receptora | |
BRPI0913930A2 (pt) | antagonistas de receptores de prostaglandinas d2 | |
DK2401269T3 (da) | Indolderivater som crth2-receptorantagonister | |
DK2821407T3 (da) | Piperidinoncarboxamidazaindan-cgrp receptorantagonister | |
AP2739A (en) | Azaindazole compounds as CCRI receptor antagonists | |
BRPI0923512A2 (pt) | antagonistas de receptores de ácido lisofosfatídico | |
EP2427430A4 (en) | 5-OXO-ETE RECEPTOR ANTAGONIST COMPOUNDS | |
BRPI0910118A2 (pt) | antagonistas de receptores do glucagon | |
DK2252581T3 (da) | Kappa-selektiv opioidreceptorantagonist | |
DK2443104T3 (da) | Disubstituerede phthalazin-hedgehog-sti-antagonister | |
EP2619204A4 (en) | TRIAZOLOPYRAZINONES AS ANTAGONISTS OF P2X7 RECEPTORS | |
BR112013002096A2 (pt) | compostos de agonistas de receptor glp-1 possuindo regiões estabilizadas | |
BR112012002336A2 (pt) | compostos aza-heterocíclicos | |
DK2799428T3 (da) | Glucagon-antagonister | |
HK1192228A1 (zh) | 受體拮抗劑 | |
DK2606042T3 (da) | Disubstituerede tetrahydrofuranyl-forbindelser som antagonister af bradykinin-b1-receptor | |
DK2539323T3 (da) | Fobindelser som Bradykinin-B1-antagonister | |
BR112012003976A2 (pt) | antagonistas de receptor glyt1 carbocíclico | |
DK2342182T3 (da) | Isoquinolinonderivater som nk3-antagonister | |
BRPI0908008A2 (pt) | Farmacóforo dual - pde4-antagonistas muscarínicos | |
EP2539706A4 (en) | ARYLPIPERAZONE ANTAGONISTS OF OPIOID RECEPTORS |